Proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), play a pivotal role in the progression of both RA and atherosclerosis, creating a shared pathological pathway that exacerbates cardiovascular risks in these patients. Here, IL6 is linked to rheumatoid arthritis.